Michael G. Brattain

Nebraska Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

63h-index14.4kcitations276works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

TGF-β signaling in diseases(78), Cancer Cells and Metastasis(33), Cancer Research and Treatments(29), Cell Adhesion Molecules Research(27), PI3K/AKT/mTOR signaling in cancer(27)

Publications276 total

Supplementary Figures 1-3 from Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells
2023Open Access
Supplementary Figures 1-3 from Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells
2023Open Access
Data from Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells
2023Open Access
Data from Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells
2023Open Access
Stathmin expression in metastatic colorectal cancer
Journal of Surgical Oncology·2021· 13 cited
Correlation of PRL3 expression with colorectal cancer progression
Journal of Surgical Oncology·2020· 11 citedOpen Access
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
Oncotarget·2020· 3 citedOpen Access
Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer
Journal of Surgical Oncology·2019· 17 citedOpen Access
Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy
Cancers·2019· 35 citedOpen Access
Growth Factor Expression and Response in Human Colon Carcinoma Cells
2019· 7 cited
Retraction: Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor β in Breast Cancer Cells
Cancer Research·2019
TGFβ and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells
Journal of Biological Chemistry·2018· 21 citedOpen Access
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
Oncotarget·2017· 52 citedOpen Access
TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells
PLoS ONE·2017· 38 citedOpen Access
Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis
Oncogene·2017· 41 citedOpen Access
Abstract 4563: Role of ezrin in PKA dependent colorectal cancer cell fate
Cancer Research·2016
AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival
Molecular and Cellular Biology·2015· 39 citedOpen Access
Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer
BMC Cancer·2014· 78 citedOpen Access
Ezrin expression and cell survival regulation in colorectal cancer
Cellular Signalling·2014· 40 cited
MicroRNA-192 suppresses liver metastasis of colon cancer
Oncogene·2013· 128 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

James K. V. Willson(10), Elizabeth Zborowska(6), Naseema M. Hoosein(5), Lu‐Zhe Sun(4), Diane E. Brattain(4), Jeffrey I. Kreisberg(4), Jennie Hauser(4), Sanford D. Markowitz(3), Lois L. Myeroff(3), Ashwani Rajput(3), Junhua Yang(3), Shazli N. Malik(3), Fengzhi Li(3), Jennifer D. Black(3), James Lutterbaugh(2), Robert S. Fan(2), Bert Vogelstein(2), W D Fine(2), Fadl Khaled(2), L E Gentry(2)